ËÄ»¢Ó°Ôº

Skip to main content
ËÄ»¢Ó°Ôº (NIH) - Turning Discovery into Health
  • Virtual Tour

Site Menu

  • Home
  • Health Information
    • Health Info Lines
    • Science Education Resources
    • ËÄ»¢Ó°ÔºClinical Research Trials and You
    • Talking to Your Doctor

    More »

    Quick Links

    • Wellness Toolkits
  • Grants & Funding

    More »

    Quick Links

  • News & Events
    • News Releases
    • Digital Media Kits
    • Media Resources
    • Media Contacts
    • Images and B-roll
    • Events
    • Social Media

    More »

    Quick Links

    • ËÄ»¢Ó°ÔºResearch Matters
  • Research & Training
    • Medical Research Initiatives
    • Science Highlights
    • Science Education
    • Research in ËÄ»¢Ó°ÔºLabs & Clinics
    • Training Opportunities
    • Library Resources
    • Research Resources
    • Clinical Research Resources
    • Safety, Regulation and Guidance

    More »

    Quick Links

  • Institutes at NIH
    • List of Institutes and Centers
    • ËÄ»¢Ó°ÔºOffice of the Director
    • Directors of ËÄ»¢Ó°ÔºInstitutes and Centers
    • ËÄ»¢Ó°ÔºInstitute and Center Contact Information

    More »

    Quick Links

  • About NIH
    • Who We Are
    • What We Do
    • Visitor Information
    • Frequently Asked Questions
    • Contact Us

    More »

    Quick Links

    • The ËÄ»¢Ó°ÔºDirector
    • Take the Virtual Tour
    • NIH…Turning Discovery Into Health®
    • Impact of ËÄ»¢Ó°ÔºResearch
    • Science, Health, and Public Trust

You are here

Home » News & Events » News Releases

News Releases

Media Advisory

Monday, February 10, 2025

Influenza A viruses adapt shape in response to environmental pressures

ËÄ»¢Ó°Ôºstudy identifies previously unknown adaptation.

Influenza A Virus (H3N2) Colorized transmission electron micrograph of influenza A virus particles, colorized red and gold, isolated from a patient sample and then propagated in cell culture. Influenza A can infect both humans and animals, including birds and pigs. More specifically, this image features the H3N2 influenza strain, isolated from a patient in Victoria, Australia, in 1975. Notable for forming both sphericNIAID

What

Influenza A virus particles strategically adapt their shape—to become either spheres or larger filaments—to favor their ability to infect cells depending on environmental conditions, according to a new study from ËÄ»¢Ó°Ôº (NIH) scientists. This previously unrecognized response could help explain how influenza A and other viruses persist in populations, evade immune responses, and acquire adaptive mutations, the researchers explain in a new study published in Nature Microbiology.

The study, led by intramural researchers at NIH’s National Institute of Allergy and Infectious Diseases (NIAID), was designed to determine why many influenza A virus particles exist as filaments. The filament shape requires more energy to form than a sphere, they state, and its abundance has been previously unexplained. To find the answer, they developed a way to observe and measure real-time influenza A virus structure during formation.

The researchers found:

  • Influenza A viruses rapidly adjust their shape when placed in conditions that reduce infection efficiency, such as the presence of antiviral antibodies or host incompatibility.
  • A virus’ shape is dynamic and impacted by its environment, rather than being fixed by strain, as commonly believed.
  • The study assessed 16 different virus-cell combinations that resulted in predictable shape trends.

Prior experiments by the research team showed that influenza A virus filaments can resist inactivation by antibodies, and the team is working to understand exactly how antibodies influence shape and infection efficiency. They also anticipate learning how viral mutations affect the shape of the virus. Many other viruses – such as measles, Ebola, Nipah, Hendra and respiratory syncytial virus – also incorporate a mixed-shape infection strategy, the researchers note.

Article

E Partlow, et al. Influenza A virus rapidly adapts particle shape to environmental pressures. Nature Microbiology DOI: (2025).

Who

Tijana Ivanovic, Ph.D., is chief of the Single Virion Biology and Biophysics Unit in the NIAID Laboratory of Viral Diseases.

NIAID conducts and supports research—at NIH, throughout the United States, and worldwide—to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the .  

About the ËÄ»¢Ó°Ôº (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. ËÄ»¢Ó°Ôºis the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about ËÄ»¢Ó°Ôºand its programs, visit www.nih.gov.

NIH…Turning Discovery Into Health®

###

Institute/Center

Contact

NIAID News Office
301-402-1663

Connect with Us

  • RSS Feed

Connect with Us

  • Contact Us
  • More Social Media from NIH

Footer

  • ËÄ»¢Ó°ÔºHome
  • Virtual Tour
  • Visitor Information
  • Frequently Asked Questions
  • Privacy Policy
  • Disclaimers
  • Accessibility
  • ËÄ»¢Ó°ÔºWebsite Archives
  • Nondiscrimination Notice
  • Freedom of Information Act

NIH…Turning Discovery Into Health®

ËÄ»¢Ó°Ôº, 9000 Rockville Pike, Bethesda, Maryland 20892

Back to Top